Alliance Wealth Advisors LLC UT trimmed its holdings in shares of Zoetis Inc. (NYSE: ZTS) by 21.5% during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 16,188 shares of the company's stock after selling 4,430 shares during the

Assetmark Inc. cut its stake in Zoetis Inc. (NYSE: ZTS) by 69.1% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 8,173 shares of the company's stock after selling 18,236 shares during the quarter. Assetmark Inc.'s holdings in Zoetis were worth

BNP PARIBAS ASSET MANAGEMENT Holding S.A. increased its holdings in Zoetis Inc. (NYSE: ZTS) by 28.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 578,621 shares of the company's stock after buying an additional 126,567 shares during the quarter.

Public Sector Pension Investment Board grew its position in Zoetis Inc. (NYSE: ZTS) by 12.7% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 38,614 shares of the company's stock after acquiring an additional 4,337 shares during the quarter. Public

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Exploring the Latest 13F Filing and Investment Strategies Mairs and Power (Trades, Portfolio) recently submitted their 13F filing for the fourth quarter of 202

Crestwood Advisors Group LLC reduced its position in shares of Zoetis Inc. (NYSE: ZTS) by 7.0% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 195,991 shares of the company's stock after selling 14,674 shares during the quarter.

Eli Lilly is included due to its strategic positioning with respect to sustainability opportunities, specifically in HealthCare Access and Innovation. Advanced Micro Devices is owned for its exceptional Corporate Resilience profile and attractive sustainability opportunity set in areas like the Digital Infrastructure build-out. Oracle stands out with a strong sustainability profile, offering notable opportunities in Digital Infrastructure, Education and the development of Enhanced Skills & Innovation.

Zoetis is reiterated as a buy, with a 20% upside to a $159/share fair value, driven by margin expansion and a cheap valuation. ZTS delivered FY 2025 revenue of $9.5B, beating guidance, and presents expanding gross margins (83.5%) and shareholder-friendly share-count reduction via buybacks. International livestock and a robust pipeline (up to 12 blockbusters) provide secular growth tailwinds, offsetting US consumer retrenchment and competitive pressures.

ABN Amro Investment Solutions lowered its holdings in shares of Zoetis Inc. (NYSE: ZTS) by 19.4% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 25,642 shares of the company's stock after selling 6,170 shares during the period. ABN